Healios KK (HLOSF)
0.9929
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
Healios Enterprise Value: 73.17M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 02, 2024 | 73.17M |
May 01, 2024 | 73.17M |
April 30, 2024 | 73.17M |
April 29, 2024 | 73.17M |
April 26, 2024 | 73.17M |
April 25, 2024 | 73.17M |
April 24, 2024 | 68.39M |
April 23, 2024 | 68.39M |
April 22, 2024 | 68.39M |
April 19, 2024 | 68.39M |
April 18, 2024 | 68.39M |
April 17, 2024 | 68.39M |
April 16, 2024 | 68.39M |
April 15, 2024 | 68.39M |
April 12, 2024 | 68.39M |
April 11, 2024 | 68.39M |
April 10, 2024 | 68.39M |
April 09, 2024 | 68.39M |
April 08, 2024 | 68.39M |
April 05, 2024 | 68.39M |
April 04, 2024 | 68.39M |
April 03, 2024 | 68.39M |
April 02, 2024 | 68.39M |
April 01, 2024 | 68.39M |
March 28, 2024 | 68.39M |
Date | Value |
---|---|
March 27, 2024 | 68.39M |
March 26, 2024 | 68.39M |
March 25, 2024 | 68.39M |
March 22, 2024 | 68.39M |
March 21, 2024 | 68.39M |
March 20, 2024 | 68.39M |
March 19, 2024 | 68.39M |
March 18, 2024 | 68.39M |
March 15, 2024 | 68.39M |
March 14, 2024 | 68.39M |
March 13, 2024 | 68.39M |
March 12, 2024 | 68.39M |
March 11, 2024 | 68.39M |
March 08, 2024 | 71.57M |
March 07, 2024 | 72.84M |
March 06, 2024 | 68.83M |
March 05, 2024 | 69.30M |
March 04, 2024 | 69.30M |
March 01, 2024 | 69.30M |
February 29, 2024 | 69.30M |
February 28, 2024 | 69.04M |
February 27, 2024 | 69.04M |
February 26, 2024 | 69.04M |
February 23, 2024 | 69.04M |
February 22, 2024 | 69.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
54.28M
Minimum
Feb 06 2024
1.085B
Maximum
Aug 14 2023
788.65M
Average
799.86M
Median
Jun 30 2022
Enterprise Value Benchmarks
Takeda Pharmaceutical Co Ltd | 72.47B |
Nxera Pharma Co Ltd | 972.42M |
PeptiDream Inc | 1.718B |
Stemcell Holdings Inc | -- |
AnGes Inc | 37.97M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -11.72M |
Revenue (Quarterly) | 0.0474M |
Total Expenses (Quarterly) | 7.369M |
EPS Diluted (Quarterly) | -0.1655 |
Profit Margin (Quarterly) | -24.73K% |
Earnings Yield | -40.02% |
Normalized Earnings Yield | -40.02 |